Dan Padawer

Dr. Dan Padawer

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TSTamar Stivi
Tamar Stivi
DPDan Padawer
Dan Padawer
NDNoor Dirini
Noor Dirini
ANAkiva Nachshon
Akiva Nachshon
BBBaruch M. Batzofin
Baruch M. Batzofin
SLStephane Ledot
Stephane Ledot
The management of mechanical ventilation (MV) remains a challenge in intensive care units (ICUs). The digitalization of healthcare and the implementation of artificial intelligence (AI) and machine learning (ML) has significantly influenced medical decision-making capabilities, potentially enhancing patient outcomes. Acute respiratory distress syndrome, an overwhelming inflammatory lung disease, is common in ICUs. Most patients require MV. Prolonged MV is associated with an increased length of stay, morbidity, and mortality. Shortening the MV duration has both clinical and economic benefits and emphasizes the need for better MV weaning management. AI and ML models can assist the physician in weaning patients from MV by providing predictive tools based on big data. Many ML models have been developed in recent years, dealing with this unmet need. Such models provide an important prediction regarding the success of the individual patient’s MV weaning. Some AI models have shown a notable impact on clinical outcomes. However, there are challenges in integrating AI models into clinical practice due to the unfamiliar nature of AI for many physicians and the complexity of some AI models. Our review explores the evolution of weaning methods up to and including AI and ML as weaning aids.

30 January 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
MSMiri Stolovich-Rain
Miri Stolovich-Rain
SKSujata Kumari
Sujata Kumari
AFAhuva Friedman
Ahuva Friedman
SKSaveliy Kirillov
Saveliy Kirillov
YSYakov Socol
Yakov Socol
ARAlexander Rouvinski
Alexander Rouvinski
Intramuscularly administered vaccines stimulate robust serum neutralizing antibodies, yet they are often less competent in eliciting sustainable “sterilizing immunity” at the mucosal level. Our study uncovers a strong temporary neutralizing mucosal component of immunity, emanating from intramuscular administration of an mRNA vaccine. We show that saliva of BNT162b2 vaccinees contains temporary IgA targeting the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus-2 spike protein and demonstrate that these IgAs mediate neutralization. RBD-targeting IgAs were found to associate with the secretory component, indicating their bona fide transcytotic origin and their polymeric multivalent nature. The mechanistic understanding of the high neutralizing activity provided by mucosal IgA, acting at the first line of defense, will advance vaccination design and surveillance principles and may point to novel treatment approaches and new routes of vaccine administration and boosting.

1 June 2019 in Asian Journal of Surgery
Verified
Journal Article
Open access
GMGad Marom
Gad Marom
Tawfik KhouryTawfik Khoury
Tawfik Khoury
SGSamir Abu Gazla
Samir Abu Gazla
HMHadar Merhav
Hadar Merhav
DPDan Padawer
Dan Padawer
AKAbed Khalaileh
Abed Khalaileh
Hydatid cyst is a zoonotic disease caused by Echinococcus genera. Surgery is needed in most cases. We aimed to describe our center's experience in the surgical management of hepatic hydated cysts (HHC). Data was retrospectively collected for patients who underwent operative management for HHC between the years 1994-2014. Sixty-nine underwent surgical treatment for HHC. Group A included 34 treated with an unroofing procedure, group B included 24 patients who underwent hepatectomy and group C included 11 patients who underwent peri-cystectomy. The median ± (range) age for groups A, B and C were 39.5 (6.5-69), 40 (17-74) and 32 (20-62), respectively (P > 0.1). Post-operative complications occurred in 16, 11 and 5 patients in group A, B and C, respectively, as assessed by clavien-dindo classification (CDC). The average CDC was significantly higher in the hepatectomy group as compared to the unroofing group (2.3 vs.1.5, P = 0.04). Recurrence was significantly higher after the unroofing procedure as compared to the hepatectomy group (P = 0.05). Surgery remains the mainstay of treatment for HHC, once surgery is pursued, the results are satisfactory.

17 July 2025 in ERJ Open Research
Verified
Journal Article
Open access
DPDan Padawer
Dan Padawer
AFAhuva Friedman
Ahuva Friedman
MSMiri Stolovich-Rain
Miri Stolovich-Rain
FDFares Darawshy
Fares Darawshy
MBMaria Billan
Maria Billan
ARAlexander Rouvinski
Alexander Rouvinski
Introduction: Functional aspects of pulmonary immunity to SARS-CoV-2 infection and BNT162b2 mRNA vaccination in humans and their correlation with upper airway and systemic immunity remain largely unexplored. The aim of the present study was to explore anti-SARS-CoV-2 immunoglobulin levels and neutralisation in the lower airway mucosa and correlate them with salivary and systemic responses among BNT162b2 recipients. Methods: Serum, saliva and bronchoalveolar lavage fluids (BALF) were collected from 100 individuals undergoing clinically indicated bronchoscopy. Anti-receptor binding domain (RBD) antibody levels and functional neutralisation were assessed. Results: Anti-RBD antibodies were present in BALF of vaccinees and recovered individuals. IgGs and IgAs were highest among four-dose vaccinees (median 0.59 nM (IgG), 0.06 nM (IgA)). Neutralisation demonstrated augmented lower-airway mucosa protection against wild-type and Delta variant, while BALF neutralisation towards Omicron was substantially lower. While IgG levels among vaccinees correlated between BALF and serum (r=0.51, p=0.001), and between saliva and serum (r=0.58, p=0.001), the IgA levels between fluids did not correlate significantly. The correlation between BALF and serum antibodies was stronger in individuals who experienced previous SARS-CoV-2 infection. Comparison of specific neutralising activity of BALF and serum anti-SARS-CoV-2 IgGs suggested a 5.5-fold increased potency of the former. Conclusion: The BNT162b2 vaccine elicits neutralising antibodies against the ancestral variants in the lower respiratory tract. The anti-RBD IgG response correlates overall between systemic and local mucosal sites, while the IgA distributions between BALF, saliva and serum seen specifically following natural exposure suggest locally specialised mucosal immunity. The higher neutralising potency of mucosal IgGs compared to circulatory IgGs highlights the protective importance of mucosal-specific IgGs in the alveolar space.

29 February 2024 in Infectious Diseases
Verified
Journal Article
Open access
DPDan Padawer
Dan Padawer
AQAbed Qadan
Abed Qadan
MKMutaz Karameh
Mutaz Karameh
FDFares Darawshy
Fares Darawshy
ALArie Laor
Arie Laor
Zvi G. FridlenderZvi G. Fridlender
Zvi G. Fridlender
Background :Nucleic acid amplification tests (NAAT) are considered the gold standard for COVID-19 diagnosis. These tests require professional manpower and equipment, long processing and swab sampling which is unpleasant to the patients. Several volatile organic compounds (VOCs) have been identified in the breath of COVID-19 patients. Detection of these VOCs using a breath test could help rapidly identify COVID-19 patients. Objective :Assess the accuracy of 'Breath of Health' (BOH) COVID-19 Fourier-transform infra-red (FTIR) Spectroscopy-based breath test. Methods :Breath samples from patients with or without symptoms suggestive for COVID-19 who had NAAT results were collected using Tedlar bags and were blindly analysed using BOH FTIR spectroscopy. BOH Measures several VOCs simultaneously and differentiating positive and negative results. BOH results were compared to NAAT results as gold standard. Results :Breath samples from 531 patients were analysed. The sensitivity of BOH breath test was found to be 79.5% and specificity was 87.2%. Positive predictive value (PPV) was 74.7% and negative predictive value (NPV) 90.0%. Calculated accuracy rate was 84.8% and area under the curve 0.834. Subgroup analysis revealed that the NPV of patients without respiratory symptoms was superior over the NPV of symptomatic patients (94.7% vs 80.7%, P-value < 0.0001) and PPV of patients with respiratory symptoms outranks the PPV of individuals without symptoms (85.3% vs 69.2%, P-value 0.0196) Conclusion :We found BOH COVID-19 breath test to be a patient-friendly, rapid, non-invasive diagnostic test with high accuracy rate and NPV that could efficiently rule out COVID-19 especially among individuals with low pre-test probability.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
DPDan Padawer
Dan Padawer
MKMutaz Karameh
Mutaz Karameh
AQAbed Qadan
Abed Qadan
FDFares Darawshy
Fares Darawshy
ALAria Laor
Aria Laor
ZFZvi G Fridlender
Zvi G Fridlender
Introduction: Nucleic acid amplification tests (NAAT) are considered the gold standard for coronavirus disease 2019 (COVID-19) diagnosis. These tests require professional manpower and equipment, long processing and are very unpleasant to the patients. Diagnostic breath tests are available for several diseases. Several volatile organic compounds (VOCs) have been identified in the breath of COVID-19 patients. Detection of these VOCs using a breath test could help rapidly identify COVID-19 patients. Aim: Assess the accuracy of 9Breath of health9 (BOH) COVID-19 Fourier-transform infrared (FTIR) Spectroscopy-based breath test Methods: Breath samples were collected from patients with or without symptoms suggestive for COVID-19 who had positive or negative NAAT results. Samples were collected using Tedlar bags and blindly analyzed using BOH FTIR spectroscopy in a central laboratory. BOH Measures several VOCs simultaneously and calculates a composite score differentiating positive and negative results. BOH results were compered to NAAT results. Results: Breath samples from 531 patients were analyzed using the BOH methodology and compared to NAAT results as gold standard. The sensitivity of BOH breath test was found to be 79.5% (95% confidence interval [CI] 72.7-85.3%) while specificity is 87.2% (95% CI 85.3-90.5%). Positive predictive value is 74.7% (95% CI 69.1-79.7%) and the negative predictive value is 90% (95% CI 86.9-92.4%). Accuracy rate is 84.8% (95% CI 81.4-87.7%) and area under the curve is 0.834 (P<0.001). Conclusion: BOH COVID-19 breath test is a patient friendly, rapid, noninvasive diagnostic test with good accuracy rate that can lead the way for additional breath tests for respiratory diseases.